Have a personal or library account? Click to login
The Association Between Early Antenatal Care and Intermittent Preventive Treatment of Malaria in Pregnancy in Sub-Saharan Africa: Effect Modification by Planned Pregnancy Status Cover

The Association Between Early Antenatal Care and Intermittent Preventive Treatment of Malaria in Pregnancy in Sub-Saharan Africa: Effect Modification by Planned Pregnancy Status

Annals of Global Health
Volume 88 (2022): Issue 1
By: Paschal Awingura Apanga,  Maxwell Tii Kumbeni and  Mary-Ann Wepiamo Chanase  
Open Access
|Jan 2022

References

  1. 1World Health Organization. World Malaria Report 2020. Accessed August 13, 2021. https://www.who.int/docs/default-source/malaria/world-malaria-reports/9789240015791-double-page-view.pdf?sfvrsn=2c24349d_5.
    Back to article
  2. 2World Health Organization. WHO Guidelines for Malaria; 2021. Accessed August 31, 2021. https://cdn.who.int/media/docs/default-source/malaria/who-ucn-gmp-2021.01-eng.pdf?sfvrsn=bd30cd9b_10&download=true.
    Back to article
  3. 3Saito M, Briand V, Min AM, McGready R. Deleterious effects of malaria in pregnancy on the developing fetus: a review on prevention and treatment with antimalarial drugs. Lancet Child Adolesc Health. 2020; 4: 761–74. DOI: 10.1016/S2352-4642(20)30099-7
    Back to article
  4. 4Eisele TP, Larsen DA, Anglewicz PA, et al. Malaria prevention in pregnancy, birthweight, and neonatal mortality: A meta-analysis of 32 national cross-sectional datasets in Africa. Lancet Infect Dis. 2012; 12: 942–9. DOI: 10.1016/S1473-3099(12)70222-0
    Back to article
  5. 5Desai M, ter Kuile FO, Nosten F, et al. Epidemiology and burden of malaria in pregnancy. Lancet Infect Dis. 2007; 7: 93–104. DOI: 10.1016/S1473-3099(07)70021-X
    Back to article
  6. 6World Health Organization. WHO policy brief for the implementation of intermittent preventive treatment of malaria in pregnancy using sulfadoxine-pyrimethamine (IPTp-SP); 2012. Accessed August 13, 2021. https://www.who.int/malaria/publications/atoz/iptp-sp-updated-policy-brief-24jan2014.pdf?ua=1.
    Back to article
  7. 7World Health Organization/AFRO. A strategic framework for malaria prevention and control during pregnancy in the African Region. World Health Organization Regional Office for Africa; 2004.
    Back to article
  8. 8Kayentao K, Garner P, van Eijk AM, et al. Intermittent preventive therapy for malaria during pregnancy using 2 vs 3 or more doses of sulfadoxine-pyrimethamine and risk of low birth weight in Africa: Systematic review and meta-analysis. JAMA. 2013; 309: 594–604. DOI: 10.1001/jama.2012.216231
    Back to article
  9. 9World Health Organization. Sexual and Reproductive Health: More women worldwide receive early antenatal care, but great inequalities remain; 2017. Accessed August 13, 2021. https://www.who.int/reproductivehealth/early-anc-worldwide/en/.
    Back to article
  10. 10Committee ES. The public health importance of antenatal care. Facts Views Vis Obgyn. 2015; 7: 5–6.
    Back to article
  11. 11Raynes-Greenow C. Gaps and challenges underpinning the first analysis of global coverage of early antenatal care. Lancet Glob Health. 2017; 5: e949–e50. DOI: 10.1016/S2214-109X(17)30346-7
    Back to article
  12. 12Nkoka O, Chuang TW, Chen YH. Association between timing and number of antenatal care visits on uptake of intermittent preventive treatment for malaria during pregnancy among Malawian women. Malar J. 2018; 17: 211. DOI: 10.1186/s12936-018-2360-z
    Back to article
  13. 13Amoako BK, Anto F. Late ANC initiation and factors associated with sub-optimal uptake of sulphadoxine-pyrimethamine in pregnancy: A preliminary study in Cape Coast Metropolis, Ghana. BMC Pregnancy Childbirth. 2021; 21: 105. DOI: 10.1186/s12884-021-03582-2
    Back to article
  14. 14Mushi V, Mbotwa CH, Zacharia A, Ambrose T, Moshi FV. Predictors for the uptake of optimal doses of sulfadoxine-pyrimethamine for intermittent preventive treatment of malaria during pregnancy in Tanzania: Further analysis of the data of the 2015–2016 Tanzania demographic and health survey and malaria indicator survey. Malar J. 2021; 20: 75. DOI: 10.1186/s12936-021-03616-2
    Back to article
  15. 15Khan S, Hancioglu A. Multiple Indicator Cluster Surveys: Delivering Robust Data on Children and Women across the Globe. Stud Fam Plann. 2019; 50: 279–86. DOI: 10.1111/sifp.12103
    Back to article
  16. 16UNICEF. Multiple Indicator Cluster Survey (MICS); 2019. Accessed August 13, 2021. https://mics.unicef.org/.
    Back to article
  17. 17National Bureau of Statistics and UNICEF. Multiple indicator cluster survey 2016–2017, survey findings report. Abuja, Nigeria; 2017.
    Back to article
  18. 18Apanga PA, Kumbeni MT, Ayamga EA, Ulanja MB, Akparibo R. Prevalence and factors associated with modern contraceptive use among women of reproductive age in 20 African countries: A large population-based study. BMJ Open. 2020; 10: e041103. DOI: 10.1136/bmjopen-2020-041103
    Back to article
  19. 19Higgins J, Green S, Collaboration. Cochrane Handbook for Systematic Reviews of Interventions: Wiley Online Library; 2008. DOI: 10.1002/9780470712184
    Back to article
  20. 20UNICEF. Designing and selecting the sample. Accessed August 13, 2021. https://mics.unicef.org/files?job=W1siZiIsIjIwMTUvMDQvMDIvMDgvMDAvMTkvODEwL01JQ1MzX0NoYXB0ZXJfNF9fX0Rlc2lnbmluZ19hbmRfU2VsZWN0aW5nX3RoZV9TYW1wbGVfMDYwMjE5LnBkZiJdXQ&sha=3d97a05358bb0e37
    Back to article
  21. 21Blot WJ, Day NE. Synergism and interaction: Are they equivalent? Am J Epidemiol. 1979; 110: 99–100. DOI: 10.1093/oxfordjournals.aje.a112793
    Back to article
  22. 22Rothman KJ, Greenland S, Walker AM. Concepts of interaction. Am J Epidemiol. 1980; 112: 467–70. DOI: 10.1093/oxfordjournals.aje.a113015
    Back to article
  23. 23Zou GY. On the estimation of additive interaction by use of the four-by-two table and beyond. Am J Epidemiol. 2008; 168: 212–24. DOI: 10.1093/aje/kwn104
    Back to article
  24. 24Knol MJ, VanderWeele TJ. Recommendations for presenting analyses of effect modification and interaction. Int J Epidemiol. 2012; 41: 514–20. DOI: 10.1093/ije/dyr218
    Back to article
  25. 25Okethwangu D, Opigo J, Atugonza S, et al. Factors associated with uptake of optimal doses of intermittent preventive treatment for malaria among pregnant women in Uganda: Analysis of data from the Uganda Demographic and Health Survey, 2016. Malar J. 2019; 18: 250. DOI: 10.1186/s12936-019-2883-y
    Back to article
  26. 26Idriss-Wheeler D, Yaya S. Exploring antenatal care utilization and intimate partner violence in Benin – are lives at stake? BMC Public Health. 2021; 21: 830. DOI: 10.1186/s12889-021-10884-9
    Back to article
  27. 27World Health Organization. Global Malaria Programme: Countries and territories certified malaria-free by WHO; 2021. Accessed August 13, 2021. https://www.who.int/teams/global-malaria-programme/elimination/countries-and-territories-certified-malaria-free-by-who.
    Back to article
  28. 28Henry M, Florey L, Youll S, Gutman JR. An analysis of country adoption and implementation of the 2012 WHO recommendations for intermittent preventive treatment for pregnant women in sub-Saharan Africa. Malar J. 2018; 17: 364. DOI: 10.1186/s12936-018-2512-1
    Back to article
  29. 29Finlayson K, Downe S. Why do women not use antenatal services in low- and middle-income countries? A meta-synthesis of qualitative studies. PLoS Med. 2013; 10: e1001373. DOI: 10.1371/journal.pmed.1001373
    Back to article
  30. 30Yaya S, Kota K, Buh A, Bishwajit G. Antenatal visits are positively associated with uptake of tetanus toxoid and intermittent preventive treatment in pregnancy in Ivory Coast. BMC Public Health. 2019; 19: 1467. DOI: 10.1186/s12889-019-7847-1
    Back to article
  31. 31Azizi SC. Uptake of intermittent preventive treatment for malaria during pregnancy with Sulphadoxine-Pyrimethamine in Malawi after adoption of updated World Health Organization policy: An analysis of demographic and health survey 2015–2016. BMC Public Health. 2020; 20: 335. DOI: 10.1186/s12889-020-08471-5
    Back to article
  32. 32Roman E, Andrejko K, Wolf K, et al. Determinants of uptake of intermittent preventive treatment during pregnancy: A review. Malar J. 2019; 18: 372. DOI: 10.1186/s12936-019-3004-7
    Back to article
  33. 33Tura H, Licoze A. Women’s experience of intimate partner violence and uptake of Antenatal Care in Sofala, Mozambique. PLoS One. 2019; 14: e0217407. DOI: 10.1371/journal.pone.0217407
    Back to article
  34. 34Oppong FB, Gyaase S, Zandoh C, et al. Intermittent preventive treatment of pregnant women in Kintampo area of Ghana with sulphadoxine-pyrimethamine (SP): trends spanning 2011 and 2015. BMJ Open. 2019; 9: e027946. DOI: 10.1136/bmjopen-2018-027946
    Back to article
DOI: https://doi.org/10.5334/aogh.3550 | Journal eISSN: 2214-9996
Journal RSS Feed
Language: English
Published on: Jan 10, 2022
Published by: Ubiquity Press
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year

© 2022 Paschal Awingura Apanga, Maxwell Tii Kumbeni, Mary-Ann Wepiamo Chanase, published by Ubiquity Press
This work is licensed under the Creative Commons Attribution 4.0 License.

Previous articleVolume 88 (2022): Issue 1Next article